Corbus Pharmaceuticals Holdings, Inc. Gains 35.63%
Thu, Jan 21, 2021 at 05:30 PM
Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ) shot up at $2.36, representing a gain of 35.6%. The stock got featured on our News Catalysts scanner on Wed 20 Jan 21 at 10:22 AM in the 'BIOTECH' category. From Wed 06 Jan 21, the stock recorded 66.67% Up Days and 50.00% Green Days
The stock spiked on Mon 31 Aug 20 at $9.78 with a volume of 3M+, and its share price has been moving sideways in recent weeks.
About Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ)
Corbus Pharmaceuticals Holdings Inc is a biopharmaceutical company. Its business involves the development of therapeutics to address serious inflammatory diseases such as cystic fibrosis, systemic sclerosis and skin-predominant dermatomyositis.
Top 10 Gainers:
- BBIG (BBIG:NASDAQ), 196.1%
- Qutoutiao Inc. (QTT:NASDAQ), 61.34%
- ADTX (ADTX:NASDAQ), 45.59%
- Ideal Power Inc. (IPWR:NASDAQ), 44.57%
- BiondVax Pharmaceuticals Ltd. (BVXV:NASDAQ), 40.66%
- Celsion Corporation (CLSN:NASDAQ), 36.47%
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 35.63%
- AzurRx BioPharma, Inc. (AZRX:NASDAQ), 34.55%
- ReWalk Robotics Ltd. (RWLK:NASDAQ), 32%
- Castor Maritime Inc. (CTRM:NASDAQ), 30.77%